Menopause Market Research Report by Treatment (Dietary Supplements and OTC Pharma Products), Distribution Challenge, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030- Product Image

Sale

Menopause Market Research Report by Treatment (Dietary Supplements and OTC Pharma Products), Distribution Challenge, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

Report
244 Pages
January 2023
Region: Global
360iResearch™
ID: 5454968

UP TO €861EUR$895USD£761GBP OFF until Mar 31^st 2023

The Global Menopause Market size was estimated at USD 16.67 billion in 2022, USD 17.79 billion in 2023, and is projected to grow at a CAGR of 6.83% to reach USD 28.29 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Menopause Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Menopause Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Menopause Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Menopause Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Menopause Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment, the market is studied across Dietary Supplements and OTC Pharma Products. The OTC Pharma Products is further studied across Hormonal products and Non-hormonal products.
Based on Distribution Challenge, the market is studied across Hospital Pharmacies, Online Stores, and Retail Pharmacies.
Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Menopause Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Menopause Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Menopause Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Menopause Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Menopause Market, including Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc, Glenmark Pharmaceuticals Ltd., Merck & Co.Inc., Mithra Pharmaceuticals, Novartis AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., and TherapeuticsMD Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Menopause Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Menopause Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Menopause Market?
4. What is the competitive strategic window for opportunities in the Global Menopause Market?
5. What are the technology trends and regulatory frameworks in the Global Menopause Market?
6. What is the market share of the leading vendors in the Global Menopause Market?
7. What modes and strategic moves are considered suitable for entering the Global Menopause Market?

Frequently Asked Questions about the Global Menopause Market

What is the estimated value of the Global Menopause Market?

The Global Menopause Market was estimated to be valued at $16.67 Billion in 2022.

What is the growth rate of the Global Menopause Market?

The growth rate of the Global Menopause Market is 6.8%, with an estimated value of $28.29 Billion by 2030.

What is the forecasted size of the Global Menopause Market?

The Global Menopause Market is estimated to be worth $28.29 Billion by 2030.

Who are the key companies in the Global Menopause Market?

Key companies in the Global Menopause Market include Abbvie Inc., Apotex Inc., Astellas Pharma Inc., Bayer AG, Cipla Inc., Eli Lilly and Company, Fervent Pharmaceuticals, LLC, GlaxoSmithKline plc and Merck & Co.Inc..

Report Attribute	Details
No. of Pages	244
Published	January 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 16.67 Billion
Forecasted Market Value ( USD ) by 2030	$ 28.29 Billion
Compound Annual Growth Rate	6.8%
Regions Covered	Global
No. of Companies Mentioned	15

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of vasomotor and other menopausal symptoms
5.1.1.2. Rising awareness regarding menopause health
5.1.1.3. Increasing number of new drug approvals for the treatment
5.1.2. Restraints
5.1.2.1. Side effects associated with hormonal products and the availability of generic medicines
5.1.3. Opportunities
5.1.3.1. Prevalence of herbal treatment for menopause
5.1.3.2. Increasing research supporting the advantages of dietary supplements
5.1.4. Challenges
5.1.4.1. Lack of advanced healthcare infrastructure in developing nations
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Menopause Market, by Treatment
6.1. Introduction
6.2. Dietary Supplements
6.3. OTC Pharma Products
6.4.1. Hormonal products
6.4.2. Non-hormonal products

7. Menopause Market, by Distribution Challenge
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Online Stores
7.4. Retail Pharmacies

8. Americas Menopause Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Menopause Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Menopause Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis, By Key Player
11.3. Market Share Analysis, By Key Player
11.4. Product Portfolio Analysis, By Key Player
11.5. Competitive Scenario
11.5.1. Merger & Acquisition
11.5.2. Agreement, Collaboration, & Partnership
11.5.3. New Product Launch & Enhancement
11.5.4. Investment & Funding
11.5.5. Award, Recognition, & Expansion

12. Company Usability Profiles
12.1. Abbvie Inc.
12.2. Apotex Inc.
12.3. Astellas Pharma Inc.
12.4. Bayer AG
12.5. Cipla Inc.
12.6. Eli Lilly and Company
12.7. Fervent Pharmaceuticals, LLC
12.8. GlaxoSmithKline plc
12.9. Glenmark Pharmaceuticals Ltd.
12.10. Merck & Co.Inc.
12.11. Mithra Pharmaceuticals
12.12. Novartis AG
12.13. Pfizer Inc.
12.14. Teva Pharmaceutical Industries Ltd.
12.15. TherapeuticsMD Inc.

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing

List of Figures
FIGURE 1. GLOBAL MENOPAUSE MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL MENOPAUSE MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL MENOPAUSE MARKET DYNAMICS
FIGURE 11. GLOBAL MENOPAUSE MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT, 2030
FIGURE 15. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2022 VS 2030 (%)
FIGURE 20. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 21. GLOBAL MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY DISTRIBUTION CHALLENGE, 2030
FIGURE 22. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD BILLION)
FIGURE 24. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD BILLION)
FIGURE 25. AMERICAS MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 26. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 27. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 28. AMERICAS MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 29. ARGENTINA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 30. BRAZIL MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 31. CANADA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 32. MEXICO MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 33. UNITED STATES MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 34. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 35. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 36. UNITED STATES MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 37. ASIA-PACIFIC MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 38. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 39. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 40. ASIA-PACIFIC MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 41. AUSTRALIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 42. CHINA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 43. INDIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 44. INDONESIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 45. JAPAN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 46. MALAYSIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 47. PHILIPPINES MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 48. SINGAPORE MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 49. SOUTH KOREA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 50. TAIWAN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 51. THAILAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 52. VIETNAM MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 53. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 54. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 55. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 56. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 57. DENMARK MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. EGYPT MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 59. FINLAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 60. FRANCE MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 61. GERMANY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. ISRAEL MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. ITALY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. NETHERLANDS MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. NIGERIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. NORWAY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 67. POLAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 68. QATAR MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 69. RUSSIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. SAUDI ARABIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 71. SOUTH AFRICA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 72. SPAIN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 73. SWEDEN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. SWITZERLAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. TURKEY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. UNITED KINGDOM MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. GLOBAL MENOPAUSE MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 79. GLOBAL MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 80. GLOBAL MENOPAUSE MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022List of Tables
TABLE 1. GLOBAL MENOPAUSE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL MENOPAUSE MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL MENOPAUSE MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL MENOPAUSE MARKET SIZE, BY OTC PHARMA PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL MENOPAUSE MARKET SIZE, BY HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL MENOPAUSE MARKET SIZE, BY NON-HORMONAL PRODUCTS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL MENOPAUSE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL MENOPAUSE MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL MENOPAUSE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 29. AMERICAS MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 30. AMERICAS MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 31. AMERICAS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 32. AMERICAS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 33. ARGENTINA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 34. ARGENTINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 35. ARGENTINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 36. BRAZIL MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 37. BRAZIL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 38. BRAZIL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 39. CANADA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 40. CANADA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 41. CANADA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 42. MEXICO MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 43. MEXICO MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 44. MEXICO MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 45. UNITED STATES MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 46. UNITED STATES MENOPAUSE MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 47. UNITED STATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 48. UNITED STATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 49. ASIA-PACIFIC MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 50. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 51. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 52. ASIA-PACIFIC MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 53. AUSTRALIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 54. AUSTRALIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 55. AUSTRALIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 56. CHINA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 57. CHINA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 58. CHINA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 59. INDIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 60. INDIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 61. INDIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 62. INDONESIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 63. INDONESIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 64. INDONESIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 65. JAPAN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 66. JAPAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 67. JAPAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 68. MALAYSIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 69. MALAYSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 70. MALAYSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 71. PHILIPPINES MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 72. PHILIPPINES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 73. PHILIPPINES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 74. SINGAPORE MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 75. SINGAPORE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 76. SINGAPORE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 77. SOUTH KOREA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 78. SOUTH KOREA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 79. SOUTH KOREA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 80. TAIWAN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 81. TAIWAN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 82. TAIWAN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 83. THAILAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 84. THAILAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 85. THAILAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 86. VIETNAM MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 87. VIETNAM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 88. VIETNAM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 93. DENMARK MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 94. DENMARK MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 95. DENMARK MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 96. EGYPT MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 97. EGYPT MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 98. EGYPT MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 99. FINLAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 100. FINLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 101. FINLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 102. FRANCE MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 103. FRANCE MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 104. FRANCE MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 105. GERMANY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 106. GERMANY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 107. GERMANY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 108. ISRAEL MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 109. ISRAEL MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 110. ISRAEL MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 111. ITALY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 112. ITALY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 113. ITALY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 114. NETHERLANDS MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 115. NETHERLANDS MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 116. NETHERLANDS MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 117. NIGERIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. NIGERIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 119. NIGERIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 120. NORWAY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 121. NORWAY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 122. NORWAY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 123. POLAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 124. POLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 125. POLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 126. QATAR MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. QATAR MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 128. QATAR MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 129. RUSSIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 130. RUSSIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 131. RUSSIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 132. SAUDI ARABIA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 133. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 134. SAUDI ARABIA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 135. SOUTH AFRICA MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 136. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 137. SOUTH AFRICA MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 138. SPAIN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. SPAIN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 140. SPAIN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 141. SWEDEN MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 142. SWEDEN MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 143. SWEDEN MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 144. SWITZERLAND MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 145. SWITZERLAND MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 146. SWITZERLAND MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 147. TURKEY MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 148. TURKEY MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 149. TURKEY MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 150. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 151. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 152. UNITED ARAB EMIRATES MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 153. UNITED KINGDOM MENOPAUSE MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 154. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY TREATMENT, 2018-2030 (USD BILLION)
TABLE 155. UNITED KINGDOM MENOPAUSE MARKET SIZE, BY DISTRIBUTION CHALLENGE, 2018-2030 (USD BILLION)
TABLE 156. GLOBAL MENOPAUSE MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 157. GLOBAL MENOPAUSE MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 158. GLOBAL MENOPAUSE MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 159. GLOBAL MENOPAUSE MARKET RANKING, BY KEY PLAYER, 2022
TABLE 160. GLOBAL MENOPAUSE MARKET SHARE, BY KEY PLAYER, 2022
TABLE 161. GLOBAL MENOPAUSE MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 162. GLOBAL MENOPAUSE MARKET MERGER & ACQUISITION
TABLE 163. GLOBAL MENOPAUSE MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 164. GLOBAL MENOPAUSE MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 165. GLOBAL MENOPAUSE MARKET INVESTMENT & FUNDING
TABLE 166. GLOBAL MENOPAUSE MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 167. GLOBAL MENOPAUSE MARKET: LICENSE & PRICING